Biomea Fusion launches underwritten public offering of common stock, pre-funded warrants
BMEA•Underwritten offering announced
Biomea Fusion launched an underwritten public offering of common stock, with pre-funded warrants available in lieu of common shares.
All securities in the deal will be sold by Biomea.
The underwriter will have a 30-day option to buy up to 15% additional shares of common stock or pre-funded warrants.
Pricing, size and timing remain subject to market conditions.
Konik Capital Partners will act as sole underwriter.
